Evaluation of false positives in the SARS-CoV-2 quantitative antigen test
- 24 June 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Infection and Chemotherapy
- Vol. 27 (10), 1477-1481
- https://doi.org/10.1016/j.jiac.2021.06.019
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Rethinking Covid-19 Test Sensitivity — A Strategy for ContainmentThe New England Journal of Medicine, 2020
- Development and Potential Usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a Pandemic ContextFrontiers in Medicine, 2020
- Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wardsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- Diagnosing COVID-19: The Disease and Tools for DetectionACS Nano, 2020
- World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)International Journal of Surgery, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- Diagnostic and analytical performance of the hepatitis B core related antigen immunoassay in hepatitis B patientsJournal of Clinical Virology, 2019
- Evaluation of the highly sensitive chemiluminescent enzyme immunoassay “Lumipulse HBsAg‐HQ” for hepatitis B virus screeningJournal of Clinical Laboratory Analysis, 2017
- A Practical Guide to Immunoassay Method ValidationFrontiers in Neurology, 2015